AVXL
Anavex Life Sciences Corp
2.40$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -28.3% | +16.0% | -6.2% | -19.1% | +2.1% | -29.5% | +198.4% | -13.9% | -70.2% | -71.6% | -5,440.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -188.5% | – | – | -37.3% | -171.4% | – | -191.1% | – | – | – | +341.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.1% | +12,233.9% | -37.5% | -98.0% | +695.5% | +20.3% | -351.5% | – | +262.6% | -99.7% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | +1,964.5% | -551.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.